Select Medical Holdings Corporation (SEM)

Select Medical Holdings Stock Forecast

Stock Price Forecast

The 3 analysts that cover Select Medical Holdings stock have a consensus rating of "Buy" and an average price target of $15.17, which forecasts a -6.65% decrease in the stock price over the next year. The lowest target is $14 and the highest is $16.5.

Price Target: $15.17 (-6.65%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$14	$15.17	$15	$16.5
Change	-13.85%	-6.65%	-7.69%	+1.54%

Analyst Ratings

The average analyst rating for Select Medical Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	0
Hold	2	2	2	2	1	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bill Sutherland Benchmark	Benchmark	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Mar 4, 2026
Ben Hendrix RBC Capital	RBC Capital	Buy → Hold Downgrades $19 → $17	Buy → Hold	Downgrades	$19 → $17	+1.54%	Mar 3, 2026
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $20 → $19	Buy	Maintains	$20 → $19	+16.92%	Feb 23, 2026
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $16 → $20	Buy	Maintains	$16 → $20	+23.08%	Oct 8, 2025
Joanna Gajuk B of A Securities	B of A Securities	Strong Buy Maintains $18 → $15	Strong Buy	Maintains	$18 → $15	-7.69%	Sep 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

5.75B

Increased by 5.45%

from 5.45B

Revenue Next Year

6.03B

Increased by 4.78%

from 5.75B

EPS This Year

1.31

Increased by 12.07%

from 1.16

EPS Next Year

1.42

Increased by 8.92%

from 1.31

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	6.20B	4.61B	4.83B	5.19B	5.45B	5.75B	6.03B
Revenue Growth	12.16%	-25.71%	4.70%	7.48%	5.12%	5.45%	4.78%
EPS	2.98	1.28	1.96	1.70	1.16	1.31	1.42
EPS Growth	54.90%	-57.12%	53.18%	-13.35%	-31.44%	12.07%	8.92%
Forward PE	-	-	-	-	-	12.45	11.43
No. Analysts	-	-	-	-	-	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	6.0B	6.3B
Avg	5.8B	6.0B
Low	5.5B	5.8B

Revenue Growth

Revenue Growth	2026	2027	2028
High	10.1%	10.0%
Avg	5.4%	4.8%
Low	1.7%	0.1%

EPS Forecast

EPS	2026	2027	2028
High	1.46	1.58
Avg	1.31	1.42
Low	1.23	1.31

EPS Growth

EPS Growth	2026	2027	2028
High	25.3%	20.7%
Avg	12.1%	8.9%
Low	5.6%	0.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.